ReviewClinical interventions in aging2017

Rivastigmine: the advantages of dual inhibition of acetylcholinesterase and butyrylcholinesterase and its role in subcortical vascular dementia and Parkinson's disease dementia.

Nagaendran Kandiah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.